wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38206284-1C1E71B1-E477-4D80-BB73-293CF9BB3BD0
Q38206284-1C1E71B1-E477-4D80-BB73-293CF9BB3BD0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38206284-1C1E71B1-E477-4D80-BB73-293CF9BB3BD0
How I determine if and when to recommend stopping tyrosine kinase inhibitor treatment for chronic myeloid leukaemia.
P2860
Q38206284-1C1E71B1-E477-4D80-BB73-293CF9BB3BD0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38206284-1C1E71B1-E477-4D80-BB73-293CF9BB3BD0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
53a47e614465d730ca0ec7b826290417a94195a8
P2860
Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular response.